InvestorsHub Logo
Followers 27
Posts 1204
Boards Moderated 0
Alias Born 09/11/2010

Re: None

Tuesday, 11/22/2011 10:34:01 AM

Tuesday, November 22, 2011 10:34:01 AM

Post# of 97237
ZGNX 110 Mill $$$ Mkt Cap 71 Mill in Cash & approved Migraine drug 40 mill in sales 2011 & projected 80 mill in 2012 BUT has phase 3 trials completed & positive on their ( First to Market ) Extended release Hydrocodone drug & also ( First to Market ) APAP free or Acetaminophen free ( causes Liver Toxicity) & FDA cracking down on it. ZGNX according to last CC has already been approached by Pharmas looking to partner up on drug & will make a decision in early 2012 whether to partner or go alone. Why go alone ??? Huge market for Hydrocodone over 6 Billion Dollars a year & Oppenhiemer has opined that ZGNX drug will do around 500 Million a year in sales. Insiders know the potential & have bought over 56% of the total outstanding shares 36.4 Million shares including the 7.1 Million shares purchased in September. Coupled with the 18 Million shares just purchased in the last 3 months by Institutions which now totals over 25 million shares & growing . BTW 18 million shares bought 11 thousand shares sold ???? FLOAT is around 4 Million shares 4 MILLION ...This is a sure shot double/triple/??? easily could be another INHX $2 to $10 quickly on FDA or Partner news or a straight buyout....INSANE Valuation here though.....

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.